Ozempic pen dosing: what TikTok gets right and wrong

What's this video probably claiming?

Based on the caption, @doctorsantiagolat is almost certainly walking Spanish-speaking viewers through how Ozempic pens work, how many you might need per month, and why dosing is doctor-dependent. That last part is genuinely good advice. The video likely explains that Ozempic comes in prefilled injection pens with set dose increments, and that the number of pens a patient needs depends on where they are in the titration schedule. Given the hashtags and the 800K+ view count, this is probably framed as a beginner explainer, possibly with a soft pitch toward a telehealth consultation. The caution against self-adjusting doses is clinically sound. What gets dicier is whether the creator accurately explains how the titration schedule works, what the actual pen configurations are, and whether the framing around "how many pens" subtly encourages viewers to think about dosing math before talking to a prescriber.

What does the science actually show?

Semaglutide (the active ingredient in Ozempic) is dosed subcutaneously once weekly, starting at 0.25 mg for four weeks, then stepping up to 0.5 mg, 1 mg, and in some patients 2 mg. Each Ozempic pen is designed for specific dose ranges: a 2 mg/1.5 mL pen delivers doses at the 0.25 mg and 0.5 mg range (up to four doses), while a 4 mg/3 mL pen covers 1 mg doses, and an 8 mg/3 mL pen covers 2 mg doses. The SUSTAIN-6 trial (Marso et al., 2016, NEJM) and the STEP trials (Wilding et al., 2021, NEJM) established the titration protocol that regulators approved. The STEP 1 trial specifically showed that patients on 2.4 mg weekly semaglutide (Wegovy formulation) lost a mean 14.9% body weight over 68 weeks. Dose titration exists for a reason: GLP-1 receptor agonists cause nausea, vomiting, and GI distress at higher doses without gradual escalation. Rushing the math on "how many pens" can push patients toward skipping titration steps.

Where does the social media noise diverge from clinical reality?

The problem with "how many pens do I need" content is that it frames a clinical titration decision as a supply and logistics question. On TikTok, this genre of video frequently bleeds into black-market sourcing behavior. Viewers do the math, figure out they need X pens per month, and then go looking for the cheapest source, which in 2024 often means unregulated compounded semaglutide from non-FDA-registered facilities. The FDA issued multiple warnings in 2023 and 2024 about compounded semaglutide products containing incorrect concentrations or unlisted additives. There is also persistent confusion between Ozempic (approved for type 2 diabetes, 2 mg max weekly dose) and Wegovy (approved for chronic weight management, 2.4 mg weekly dose). These are not interchangeable prescriptions even though the active molecule is identical. Creators who discuss pen quantities without clarifying this distinction, even unintentionally, contribute to off-label use patterns that carry real clinical risk.

What should you actually know?

If you are starting semaglutide for weight management or type 2 diabetes, the number of pens you need is genuinely not a fixed number and changes across your titration schedule. Most patients spend four weeks at each dose step, meaning pen configurations and quantities shift every one to two months. A prescriber or pharmacist should be doing this math with you, not a TikTok video. The 0.25 mg starting dose pen, for example, delivers four weekly injections, so one pen covers your first month. At 1 mg weekly, you also get roughly four doses per pen, but the pen size and concentration are different. Mixing these up is not a minor error. Studies like Rubino et al. (2021, JAMA) also show that weight regain after stopping semaglutide is significant, averaging two-thirds of lost weight within one year, so understanding long-term treatment planning matters far more than pen counting. Talk to a prescriber who reviews your metabolic history before you start calculating supply.